Betta Pharmaceuticals Co., Ltd.

Betta Pharmaceuticals Co., Ltd. is a legitimate Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622) of Hong Kong on 2025-10-14 (operating for under 1 year (Newly Incorporated)). According to the official register of the Hong Kong Companies Registry (CR), the entity holds an active statutory status of [Live / In Operation] (Statutory records last verified: November 2025).

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [78937304] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [Pending registration] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To retrieve the complete certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier UBO beneficial ownership penetration, apply through 86hc.com for an official due diligence dossier.

According to the statutory registers of the Hong Kong Companies Registry, Betta Pharmaceuticals Co., Ltd. has never changed its corporate name since incorporation, maintaining its current registered legal name continuously.

Yes. 86hc.com comprehensively indexes the official filing registers of the Hong Kong Companies Registry, supporting verified retrieval of official statutory dossiers for this corporation. Pursuant to Section 107 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days of each incorporation anniversary. Available verified original dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and shareholders), Incorporation Form (Form NNC1/NC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A). Rapid document fulfillment within 15-30 minutes and Certified True Copies (CTC) signed by practicing Hong Kong CPAs are supported.

According to multi-dimensional checks across 32 Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across all 32 Hong Kong statutory regulatory registers (including HKMA, SFC, TCSP, Customs MSO/DPMS), this entity holds no special financial licensing, operating as an ordinary commercial company limited by shares; 2. Judicial Litigation & Winding-Up: screening across the Court of Final Appeal, High Court, District Court, and Official Receiver's Office (ORO) shows no active compulsory winding-up petitions on file.